Condition
Deficiency of Anterior Cruciate Ligament
Total Trials
5
Recruiting
0
Active
0
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
20%
1 of 5 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed5
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT02626975CompletedPrimary
MRI Study of Ballooning and Ligamentisation Short Transplants ACL Hamstring According to Technical DT4
NCT00529958Not ApplicableCompleted
Comparison of Three Methods for Anterior Cruciate Ligament Reconstruction
NCT02382341CompletedPrimary
BIOSURE™ HEALICOIL™ PK Bone In-growth Study
NCT02755376Not ApplicableCompletedPrimary
Development of Novel Strategy for Treatment of Anterior Cruciate Ligament (ACL) Injury Using Stem Cell
NCT01607437CompletedPrimary
Clinical Follow-up After ACL Reconstruction
Showing all 5 trials